In Luxembourg, the National Strategy and Action Plan on Drugs and Addictions 2015-19 addresses illicit drugs, alcohol, tobacco, psychotropic drugs and behavioural addictions. The strategy is built around the two pillars of drug demand and drug supply reduction and the four transversal themes of harm reduction, research and information, international cooperation and coordination.
Its overall objective is to contribute to achieving a high level of protection in terms of public health, public security and social cohesion. This high-level objective is, in turn, supported by six sub-objectives across the strategy’s pillars and transversal axis. The implementation of the strategy is supported by a 60-point plan that spreads the actions across the pillars and transversal areas. More precisely, the National Strategy and Action Plan on Drugs and Addictions 2015-19 is designed to contribute to preventing drug use and addictive behaviours, developing and maintaining diversity and quality in care and treatment offers, and tangibly reducing drug use prevalence among the general population as well as health and social damage generated by illicit drug use and drug trafficking. The Action Plan’s priorities include general and indicated prevention, diversification and decentralisation of care provision, the further development of substitution treatment, specific care for ageing drug users, supervised housing offers, the fight against infectious diseases among drug users and new psychoactive substances.
Like other European countries, Luxembourg evaluates its drug policy and strategy using routine indicator monitoring and specific research projects. In 2014, an external mixed-methods evaluation of the 2010-14 national strategy’s implementation was completed and used in the development of the current National Strategy 2015-19. In 2019, an external evaluation of the 2015-19 action plan is planned, and this will support the development of a new National Strategy and Action Plan on Drugs and Addictions 2020-24.
At the national level, the Interministerial Commission on Drugs (ICD) coordinates the activities of different ministries involved in the drugs area. The Commission is chaired by the National Drug Coordinator, who is appointed by the Minister of Health. The Commission is composed of senior delegates from the main governmental departments, the Ministry of Health and invited experts, and it constitutes the top advisory level with respect to the coordination and orientation of drug actions. Both the ICD and the Ministry of Health are responsible for the implementation of national drugs strategies and action plans, supervising field activities and guaranteeing an effective consultation process with other ministries. While the National Drug Coordinator is responsible for coordination in the area of demand reduction, the Ministry of Justice and the Ministry of Interior Security are responsible for supply reduction and the Ministry of Foreign Affairs is responsible for international cooperation.